查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1753906

2025 年至 2033 年出血性疾病治疗市场报告（按类型、药物类别、配销通路、最终用户和地区）

Bleeding Disorders Treatment Market Report by Type, Drug Class, Distribution Channel, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球出血性疾病治疗市场规模达 158 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 248 亿美元，2025-2033 年期间的成长率 (CAGR) 为 4.87%。

出血性疾病包括血友病A和B、血管性血友病、特发性血小板减少性紫斑症 (ITP) 以及维生素K和因子II、V、VII、X和XII缺乏症。它们是一类会扰乱个体血液凝固过程的疾病。它们还可能导致受伤后大量出血和长时间出血。其症状包括月经过多、容易瘀青、频繁流鼻血、轻微割伤出血过多、关节出血。这些疾病的诊断是透过全血球计数 (CBC)、血小板聚集和出血时间等血液检查进行的。其治疗方法包括药物治疗，如肾上腺色素单缩氨基脲、视网膜出血、鼻出血、氨基己酸、抑肽酶和铁补充剂。这些药物有助于减轻特定症状并延长患者的生命。出血性疾病的治疗还包括输血、替代疗法以及注射凝血因子和血浆。

出血性疾病治疗市场趋势：

出血性疾病在人群中日益普遍的盛行率以及老年人口的不断增长（老年人更容易患上此类疾病）是推动全球市场发展的关键因素。此外，越来越多的医疗保险政策为出血性疾病治疗提供经济援助并降低医疗费用，这也对市场产生了积极影响。此外，许多国家的管理机构正在提高人们对捐血和血浆捐赠的认识。他们也积极推广捐血活动。此外，人们对有效治疗方案可用性的认识不断提高，也为市场带来了积极的前景。此外，研发活动以及医疗基础设施和诊断技术的显着改进预计将为市场带来良好的前景。

本报告回答的关键问题：

  • 全球出血性疾病治疗市场迄今表现如何，未来几年将如何表现？
  • COVID-19 对全球出血性疾病治疗市场有何影响？
  • 主要的区域市场有哪些？
  • 根据类型，市场区隔是怎样的？
  • 根据药品类别，市场是如何分類的？
  • 根据配销通路，市场如何划分？
  • 根据最终用户，市场是如何分類的？
  • 该产业的价值链分为哪些阶段？
  • 该行业的主要驱动因素和挑战是什么？
  • 全球出血性疾病治疗市场的结构是如何的？主要参与者是谁？
  • 产业竞争程度如何？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球出血性疾病治疗市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场细分：依类型

  • 血友病A
  • 血友病B
  • 血管性血友病
  • 其他的

第七章：市场区隔：依药品类别

  • 血浆来源的凝血因子浓缩物
    • 关键部分
      • 第八因子
      • 凝血因子IX
      • 血管性血友病的因素
      • 活性凝血酶原复合物浓缩物
  • 重组凝血因子浓缩物
    • 关键部分
      • 第八因子
      • 血管性血友病的因素
      • 凝血因子IX
  • 去氨加压素
  • 抗纤溶药物
  • 纤维蛋白密封剂
  • 其他的

第八章：市场区隔：按配销通路

  • 医院药房
  • 零售药局
  • 网上商店

第九章：市场区隔：依最终用户

  • 医院
  • 诊所
  • 学术和研究机构

第十章：市场细分：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第 15 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • AbbVie Inc
    • Alnylam Pharmaceuticals Inc.
    • Bayer AG
    • CSL Behring (CSL Limited)
    • Grifols SA
    • Johnson & Johnson
    • Novo Nordisk A/S
    • Octapharma AG
    • Pfizer Inc.
    • Sanofi SA
    • Takeda Pharmaceutical Company Limited
    • Wellona Pharma
Product Code: SR112025A6567

The global bleeding disorders treatment market size reached USD 15.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 24.8 Billion by 2033, exhibiting a growth rate (CAGR) of 4.87% during 2025-2033.

Bleeding disorders involve hemophilia A and B, Von Willebrand disease, idiopathic thrombocytopenic purpura (ITP), and deficiencies of vitamin K and factors II, V, VII, X, and XII. They are a class of conditions that disrupt the blood clotting process in an individual. They can also lead to heavy and prolonged bleeding after an injury. They have symptoms, including heavy menstrual bleeding, easy bruising, frequent nosebleeds, excessive bleeding from minor cuts, and joint bleeding. They are diagnosed through blood tests of complete blood count (CBC), platelet aggregation, and bleeding time. Their treatment comprises medications, including adrenochrome monosemicarbazone, retinal hemorrhage, epistaxis, aminocaproic acid, aprotinin, and iron supplements. These medications can aid in minimizing specific symptoms and prolonging the life of patients. Bleeding disorders treatment also includes blood transfusion, replacement therapy, and injections of a clotting factor and plasma.

Bleeding Disorders Treatment Market Trends:

The increasing prevalence of bleeding disorders among the masses and the rising geriatric population, which is more susceptible to these medical conditions, are among the key factors driving the market around the world. Moreover, the growing adoption of health insurance policies that provide financial assistance for bleeding disorders treatment and reduce healthcare expenses is influencing the market positively. In addition, governing agencies of numerous countries are generating awareness about blood and plasma donation. They are also undertaking initiatives to promote blood donation camps. Apart from this, the increasing awareness about the availability of effective treatment alternatives is creating a positive outlook for the market. Furthermore, research and development (R&D) activities and considerable improvements in the healthcare infrastructure and diagnostic technologies are expected to provide a favorable outlook to the market.

Key Market Segmentation:

Breakup by Type:

  • Hemophilia A
  • Hemophilia B
  • Von Willebrand Disease
  • Others

Breakup by Drug Class:

  • Plasma-derived Coagulation Factor Concentrates
    • Factor VIII
    • Factor IX
    • Factor for Von Willebrand Disease
    • Activated Prothrombin Complex Concentrate
  • Recombinant Coagulation Factor Concentrates
    • Factor VIII
    • Factor for Von Willebrand Disease
    • Factor IX
  • Desmopressin
  • Antifibrinolytics
  • Fibrin Sealants
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Stores

Breakup by End User:

  • Hospitals
  • Clinics
  • Academic and Research Institutes

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc, Alnylam Pharmaceuticals Inc., Bayer AG, CSL Behring (CSL Limited), Grifols S.A., Johnson & Johnson, Novo Nordisk A/S, Octapharma AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited and Wellona Pharma.

Key Questions Answered in This Report:

  • How has the global bleeding disorders treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global bleeding disorders treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the drug class?
  • What is the breakup of the market based on the distribution channel?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global bleeding disorders treatment market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Bleeding Disorders Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Hemophilia A
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Hemophilia B
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Von Willebrand Disease
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Drug Class

  • 7.1 Plasma-derived Coagulation Factor Concentrates
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Factor VIII
      • 7.1.2.2 Factor IX
      • 7.1.2.3 Factor for Von Willebrand Disease
      • 7.1.2.4 Activated Prothrombin Complex Concentrate
    • 7.1.3 Market Forecast
  • 7.2 Recombinant Coagulation Factor Concentrates
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Factor VIII
      • 7.2.2.2 Factor for Von Willebrand Disease
      • 7.2.2.3 Factor IX
    • 7.2.3 Market Forecast
  • 7.3 Desmopressin
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Antifibrinolytics
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Fibrin Sealants
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Academic and Research Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 AbbVie Inc
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Alnylam Pharmaceuticals Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bayer AG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 CSL Behring (CSL Limited)
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Grifols S.A.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Johnson & Johnson
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Novo Nordisk A/S
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Octapharma AG
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 SWOT Analysis
    • 15.3.9 Pfizer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Sanofi S.A.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Takeda Pharmaceutical Company Limited
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Wellona Pharma
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Bleeding Disorders Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Bleeding Disorders Treatment Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Bleeding Disorders Treatment Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Bleeding Disorders Treatment Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Bleeding Disorders Treatment Market: Breakup by Drug Class (in %), 2024
  • Figure 6: Global: Bleeding Disorders Treatment Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Bleeding Disorders Treatment Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Bleeding Disorders Treatment Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Bleeding Disorders Treatment (Hemophilia A) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Bleeding Disorders Treatment (Hemophilia A) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Bleeding Disorders Treatment (Hemophilia B) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Bleeding Disorders Treatment (Hemophilia B) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Bleeding Disorders Treatment (Von Willebrand Disease) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Bleeding Disorders Treatment (Von Willebrand Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Bleeding Disorders Treatment (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Bleeding Disorders Treatment (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Bleeding Disorders Treatment (Plasma-derived Coagulation Factor Concentrates) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Bleeding Disorders Treatment (Plasma-derived Coagulation Factor Concentrates) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Bleeding Disorders Treatment (Recombinant Coagulation Factor Concentrates) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Bleeding Disorders Treatment (Recombinant Coagulation Factor Concentrates) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Bleeding Disorders Treatment (Desmopressin) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Bleeding Disorders Treatment (Desmopressin) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Bleeding Disorders Treatment (Antifibrinolytics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Bleeding Disorders Treatment (Antifibrinolytics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Bleeding Disorders Treatment (Fibrin Sealants) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Bleeding Disorders Treatment (Fibrin Sealants) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Bleeding Disorders Treatment (Other Drug Classes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Bleeding Disorders Treatment (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Bleeding Disorders Treatment (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Bleeding Disorders Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Bleeding Disorders Treatment (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Bleeding Disorders Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Bleeding Disorders Treatment (Online Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Bleeding Disorders Treatment (Online Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Bleeding Disorders Treatment (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Bleeding Disorders Treatment (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Bleeding Disorders Treatment (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Bleeding Disorders Treatment (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Bleeding Disorders Treatment (Academic and Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Bleeding Disorders Treatment (Academic and Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: North America: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: North America: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: United States: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: United States: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Canada: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Canada: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Asia-Pacific: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Asia-Pacific: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: China: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: China: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Japan: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Japan: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: India: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: India: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: South Korea: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: South Korea: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Australia: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Australia: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Indonesia: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Indonesia: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Others: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Others: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Europe: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Europe: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Germany: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Germany: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: France: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: France: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: United Kingdom: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: United Kingdom: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Italy: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Italy: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Spain: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Spain: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Russia: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Russia: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Others: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Others: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Latin America: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Latin America: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Brazil: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Brazil: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Mexico: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Mexico: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Others: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Others: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Middle East and Africa: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Middle East and Africa: Bleeding Disorders Treatment Market: Breakup by Country (in %), 2024
  • Figure 89: Middle East and Africa: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 90: Global: Bleeding Disorders Treatment Industry: SWOT Analysis
  • Figure 91: Global: Bleeding Disorders Treatment Industry: Value Chain Analysis
  • Figure 92: Global: Bleeding Disorders Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Bleeding Disorders Treatment Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Bleeding Disorders Treatment Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Bleeding Disorders Treatment Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
  • Table 4: Global: Bleeding Disorders Treatment Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Bleeding Disorders Treatment Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Bleeding Disorders Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Bleeding Disorders Treatment Market: Competitive Structure
  • Table 8: Global: Bleeding Disorders Treatment Market: Key Players